FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5                       
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

FIELDS HEIDI
2. Issuer Name and Ticker or Trading Symbol

AGILENT TECHNOLOGIES, INC. [ A ]
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__X__ Director                    _____ 10% Owner
_____ Officer (give title below)    _____ Other (specify below)
(Last)          (First)          (Middle)

5301 STEVENS CREEK BLVD, MS 1A-LC
3. Date of Earliest Transaction (MM/DD/YYYY)

9/20/2019
(Street)

SANTA CLARA, CA 95051
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock  9/20/2019    S    4000  D $78.5641 (1) 7311  I  Living Trust (2)
Common Stock                 53287.23  D   

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares

Explanation of Responses:
(1)  The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions ranging from $78.5622 and $78.575, inclusive. The reporting person undertakes to provide to Agilent Technologies, Inc., any security holder of Agilent Technologies, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote of this Form 4.
(2)  Shares held by the Heidi K. Fields Living Trust of which Ms. Kunz is a trustee.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
FIELDS HEIDI
5301 STEVENS CREEK BLVD, MS 1A-LC
SANTA CLARA, CA 95051
X



Signatures
/s/ P. Diana Chiu, attorney-in-fact for Ms. Kunz 9/24/2019
**Signature of Reporting Person Date


Agilent Technologies (NYSE:A)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Agilent Technologies Charts.
Agilent Technologies (NYSE:A)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Agilent Technologies Charts.

Agilent Technologies, Inc. News

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Padraig McDonnell Assumes Agilent CEO Role
Wednesday 1 May 2024 (16 hours ago) • Business Wire
Agilent Announces the NovoCyte Opteon, a Cutting-Edge Spectral Flow Cytometry Solution
Wednesday 1 May 2024 (17 hours ago) • Business Wire
Agilent Names Simon May to Lead Diagnostics and Genomics Group
Monday 29 April 2024 (3 days ago) • Business Wire
Reitmans (Canada) Limited Reports Fiscal 2024 and Fourth Quarter Fiscal 2024 Financial Results
Thursday 18 April 2024 (2 weeks ago) • PR Newswire (Canada)
Agilent Receives Scientists' Choice Awards for Sustainability
Tuesday 16 April 2024 (2 weeks ago) • Business Wire
Agilent Receives European IVDR Class C Certification for GenetiSure Dx Postnatal Assay
Monday 15 April 2024 (2 weeks ago) • Business Wire
Agilent Brings Great Science to Life at Analytica 2024
Thursday 4 April 2024 (4 weeks ago) • Business Wire
Agilent at AACR 2024: Empowering Breakthroughs in Cancer Research and Diagnostics
Wednesday 3 April 2024 (4 weeks ago) • Business Wire
Agilent and UC San Diego Launch Center of Excellence in Cellular Intelligence
Tuesday 2 April 2024 (4 weeks ago) • Business Wire
Agilent Launches New Advanced Dilution System to Increase Lab Efficiency
Monday 1 April 2024 (1 month ago) • Business Wire
Agilent Presents 2024 Darlene Solomon Award to University of Cambridge Researcher Joycelyn Tan
Thursday 14 March 2024 (2 months ago) • Business Wire
Form 144 - Report of proposed sale of securities
Friday 8 March 2024 (2 months ago) • Edgar (US Regulatory)